![Italy approves GSK-Vir antibody to treat COVID-19](https://www.thepeninsulaqatar.com/uploads/2021/07/13/post_main_cover/e56e07132996d57f28846e902241e72e345fecf0.jpeg)
Italy approves GSK-Vir antibody to treat COVID-19
The Peninsula
MILAN - Italy approved the temporary distribution of a coronavirus antibody treatment by Britain's GlaxoSmithKline and U.S. company Vir Biotechnology , the health ministry said in a statement on Tuesday.
The therapy, named Sotrovimab, can be distributed until Jan. 31, 2022, it said, adding the authorisations for all the other monoclonal treatments already in use in the country had also been extended to the same date. Antibody treatments are designed to decrease the severity of COVID-19 among patients diagnosed with the infection.More Related News